Potassium chloride 40 MEQ Powder for Oral Solution — RxCUI 2728724
RxNorm drug concept · Semantic clinical drug
RxCUI 2728724
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2728724
Official namePotassium chloride 40 MEQ Powder for Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asK+ chloride 40 MEQ Powder for Oral Solution; potassium chloride 40 MEQ (3 GM) Powder for Oral Solution; Pot chloride 40 MEQ Powder for Oral Solution; potassium chloride 3 GM Powder for Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Potassium Chloride: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You're right that food is the first line — bananas, potatoes, and leafy greens are all rich in potassium. But sometimes diet alone isn't enough, especially if you're taking a diure...
- Why did my doctor prescribe potassium chloride? I thought potassium just came from bananas.
- Yes — always take oral tablets or capsules with a meal or right after eating. Taking them on an empty stomach can irritate or even ulcerate the lining of your stomach or intestines...
- Do I have to take it with food? What happens if I forget?
🕸️ Concept Web — How Potassium chloride 40 MEQ Powder for Oral Soluti... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Potassium chloride 40 MEQ Powder for Oral Solution
RxCUI 2728724 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Potassium chloride
8591IN
-
Potassium chloride
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Potassium chloride Powder for Oral Solution
1867543SCDF -
Potassium chloride Oral Powder Product
1295399SCDG -
Potassium chloride Oral Product
1160489SCDG -
Powder for Oral Solution
1540455DF -
Oral Powder Product
1294711DFG -
Oral Product
1151131DFG
-
Potassium chloride Powder for Oral Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Potassium chloride 40 MEQ
2728723SCDC
-
Potassium chloride 40 MEQ
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Potassium chloride 40 MEQ
SCDC · 2728723 -
Potassium chloride Powder for Oral Solution
SCDF · 1867543 -
Potassium chloride Oral Powder Product
SCDG · 1295399 -
Potassium chloride Oral Product
SCDG · 1160489
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2728724 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71085-0083-30 | 30 POUCH in 1 CARTON (71085-083-30) / 3.16 g in 1 POUCH (71... | Potassium Chloride | IPG Pharmaceuticals, Inc. | 2025-12-01 |
Observed labelers:
IPG Pharmaceuticals, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.